CLSI eNews - 1 February 2008 (Plain Text Version)

Return to Graphical Version | Search back issues | Print all articles

In this issue:
Note on printing single articles: Each selected individual article will appear at the bottom of this screen...please scroll down to view/print the selected article.

News
Executive Vice President's Message
Volunteer Focus
CLSI Announces Keynote Address as Part of Upcoming To Your Good Health Workshop
New Website and New Catalog Supplement
Lab Guidelines & Standards
The Evolution of POC Connectivity
New 2008 Teleconference Series
Press Releases
Standards Status
Vote and Deadlines
Recently Approved Documents
Events
Upcoming Events
Upcoming Presentations
CLSI Meeting Calendar
Participate in CLSI
Volunteer
Career Opportunities
New and Sustaining Members
Update Your Subscription

Recently Approved Documents

User Protocol for Evaluation of Qualitative Test Performance (EP12-A2)
Collection, Transport, and Processing of Blood Specimens for Testing Plasma-Based Coagulation Assays and Molecular Hemostasis Assays (H21-A5)
Protocol for the Evaluation, Validation, and Implementation of Coagulometers; Approved Guideline (H57-A)
Antimicrobial Susceptibility Testing Standard (M100-S18)

EP12-A2—User Protocol for Evaluation of Qualitative Test Performance; Approved Guideline—Second Edition
This document provides a consistent approach for protocol design and data analysis when evaluating qualitative diagnostic tests. Guidance is provided for both precision and method-comparison studies.
Purchase here.

H21-A5—Collection, Transport, and Processing of Blood Specimens for Testing Plasma-Based Coagulation Assays and Molecular Hemostasis Assays; Approved Guideline—Fifth Edition
This guideline contains procedures for collecting, transporting, and storing blood; processing blood specimens; storing plasma for coagulation testing; and general recommendations for performing the tests.
Purchase here.

H57-A—Protocol for the Evaluation, Validation, and Implementation of Coagulometers; Approved Guideline
This document provides guidance and procedures to the end user and manufacturer for the selection, evaluation, validation, and implementation of a laboratory coagulometer.
Purchase here.

Second Notice

M100-S18— Performance Standards for Antimicrobial Susceptibility Testing; Eighteenth Informational Supplement
The latest recommendations for detecting emerging resistance—arranged in tabular form. Includes updated tables from CLSI’s newest disk (M02-A9) susceptibility and MIC (M07-A7) testing standards.
Purchase here.

Our procedures have been designed to ensure that consensus has been achieved when a standard or guideline is published at the approved level. This means that a document has been rigorously reviewed by the authoring subcommittee, the area committee overseeing the project, the Board of Directors, and the medical-testing community that participates in the consensus process by carefully reviewing and commenting on the standard or guideline.

You may automatically receive or select approved-level documents as a member benefit. Find out more about joining CLSI: view membership options and benefits.